Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: Quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction

Journal of Neuroendocrinology

Volumn 8, Issue 8, 1996, Pages 605-610

  Murabe, Hiroyuki ^a   Shimatsu, Akira ^a   Ihara, Chihiro ^a   Mizuta, Haruo ^a   Nakamura, Yoshio ^a   Nagata, Izumi ^a   Kikuchi, Haruhiko ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Pituitary adenoma; Quantitative RT PCR; Somatostatin receptor subtypes; Somatotroph adenoma

Indexed keywords

BETA ACTIN; CYCLOPHILIN; GROWTH HORMONE; MESSENGER RNA; OCTREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOMATIC CELL; TUMOR VOLUME;

EID: 0029777542     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.1996.tb00695.x     Document Type: Article

References (41)

1. Reichlin S. Somatostatin. N Engl J Med 1983; 309: 1495-1501, 1556-1563.
2. Yamada Y, Post SR, Wang K et al. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 1992; 89: 251-255.
3. Yamada Y, Reisine T, Law SF et al. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol 1992; 6: 2136-2142.
4. Yamada Y, Kagimoto S, Kubota A et al. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTRS) human somatostatin receptor subtype. Biochem Biophys Res Commun 1993; 195: 844-852.
5. Reisine T, Bell GI. Molecular properties of somatostatin receptors. Neuroscience 1995; 67: 777-790.
6. Bell GI, Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci 1993; 16: 34-38.
7. Rens-Domiano S, Law SF, Yamada Y et al. Pharmacological properties of two cloned somatostatin receptors. Mol Pharmacol 1992; 42: 28-34.
8. Raynor K, Murphy WA, Coy DH et al. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol 1993; 43: 838-844.
9. Raynor K, O'Carroll A-M, Kong H et al. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol Pharmacol 1993; 44: 385-392.
10. O'Carroll A-M, Raynor K, Lolait SJ, Reisine T. Characterization of cloned human somatostatin receptor SSTR5. Mol Pharmacol 1994; 46: 291-298.
11. Lamberts SWJ, Krenning EP, Reubi J-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991; 12: 450-482.
12. Kubota A, Yamada Y, Kagimoto S et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 1994; 93: 1321-1325.
13. Miller GM, Alexander JM, Bikkal HA et al. Somatostatin receptor subtype gene expression in pituitary adenomas. J Clin Endocrinol Metab 1995; 80: 1386-1392.
14. Greenman Y, Melmed S. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab 1994; 78: 398-403.
15. Reubi J-C, Schaer JC, Waser B, Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 1994; 54: 3455-3459.
16. Greenman Y, Melmed S. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 1994; 79: 724-729.
17. Becker-Andre M, Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by PCR aided transcript titration assay (PATTY). Nucleic Acids Res 1989; 17: 9437-9446.
18. Sheflin LG, Fucile NW, Ozawa S, Spaulding SW. Thyroxine increases the levels of epidermal growth factor messenger ribonucleic acid (EGF mRNA) in the thyroid in vivo, as revealed by quantitative reverse transcription polymerase chain reaction with an internal control EGF mRNA. Endocrinology 1993; 132: 2319-2324.
19. Moyse E, Le Dafniet M, Epelbaum J et al. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas. J Clin Endocrinol Metab 1985; 61: 98-103.
20. Bertherat J, Brue T, Enjalbert A et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 1992; 75: 540-546.
21. Reubi J-C, Krenning EP, Lamberts SWJ, Kvols L. Somatostatin receptors in malignant tissues. J Steroid Biochem Mol Biol 1990; 37: 1073-1077.
22. Levy A, Eckland DJA, Gurney AM et al. Somatostatin and thyrotrophin-releasing hormone response and receptor status of a thyrotrophin secreting pituitary adenoma: clinical and in vitro studies. J Neuroendocrinol 1989; 1: 321-326.
23. Reubi J-C, Heitz PU, Landolt AM. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: Evidence for different tumor subclasses. J Clin Endocrinol Metab 1987; 65: 65-73.
24. Lamberts SWJ, Krenning EP, Bakker WH et al. Somatostatin receptor imaging in the diagnosis of pituitary and parasellar tumors. In: Melmed S, Robbins RJ, eds. Molecular and clinical advances in pituitary disorders, Boston: Blackwell Science Ptd, 1991; 285-292.
25. Lamberts SWJ. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 1988; 9: 417-436.
26. Lamberts SWJ, Zweens M, Klijn JGM et al. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly. Clin Endocrinol (Oxf) 1986; 25: 201-212.
27. Ikuyama S, Nawata H, Kato K et al. Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients. J Clin Endocrinol Metab 1986; 62: 729-733.
28. Reubi J-C, Landolt AM. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. J Clin Endocrinol Metab 1989; 68: 844-850.
29. Bertherat J, Chanson P, Dewailly D et al. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Horm Res 1992; 38: 94-99.
30. Bertherat J, Chanson P, Dewailly D et al. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. J Clin Endocrinol Metab 1993; 77: 1577-1583.
31. O'Carroll A-M, Krempels K. Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endocrinology 1995; 136: 5224-5227.
32. Day R, Dong W, Panetta R et al. Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology 1995; 136: 5232-5235.
33. Plöckinger U, Reichel M, Fett U et al. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. J Clin Endocrinol Metab 1994; 79: 1416-1423.
34. Reubi J-C, Laissue JA. Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol Sci 1995; 16: 110-115.
35. Buscail L, Estève J-P, Saint-Laurent N et al. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA 1995; 92: 1580-1584.
36. Srikant CB. Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary cells. Biochem Biophys Res Commun 1995; 209: 400-406.
37. Shimatsu A, Hattori N, Tanoh T et al. Clinical application of a sensitive immunoradiometric assay for human growth hormone. Folia Endocrinol Jpn 1990; 66: 715-725.
38. Chomczynski P, Sacchi N. Single-step mehtod of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1990; 162: 156-159.
39. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15: 532-536.
40. Ponte P, Ng SY, Engel J et al. Evolutionary conservation in the untranslated regions of actin mRNA: DNA sequence of a human beta-actin cDNA. Nucleic Acid Res 1984; 12: 1687-1696.
41. Pellegrini I, Barlier A, Gunz G et al. Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1994; 79: 189-196.